Both the LYMA Laser and the LYMA Laser PRO incorporate exactly the same powerful, transformative laser technology. The difference is in the size of the treatment lens. The LYMA Laser is engineered with a 8cm² treatment lens, optimised to transform skin on the face, neck and targeted areas of concern from 3 minutes daily. The LYMA Laser PRO is engineered with a bigger 30cm² treatment lens, optimised to transform skin on the face, neck and full body, faster.

The LYMA Laser PRO is engineered with a bigger treatment lens of 30cm², optimised to transform skin on the face, neck and full body. Faster.

The LYMA Laser PRO is certified as a cosmetic device, engineered to deliver a deep biological penetration. There is a wealth of published medical evidence to demonstrate the power of cold laser technology to heal torn muscles, heal skin and wounds, and repair soft tissue. The LYMA Laser however is a cosmetic device and is not a medical device.​

Not only is there absolutely no pain or discomfort experienced when using the LYMA Laser PRO, its advanced laser technology causes no sensation whatsoever whilst using it.  ​

This pain free cosmetic laser is engineered with powerful, patented ultra diffuse lenses which remove all the laser’s intense heat by the time the near-infrared light reaches the skin. The light from the LYMA Laser is engineered to penetrate deep beneath the skin’s surface whilst retaining biological power. This stimulates surplus collagen production, to build a more dense and more elastic dermis and thicker and plumper epidermis. The result is transformed skin.​

It’s the concept of causing damage in order to stimulate collagen production that makes other cosmetic laser technologies unsuitable for people with Black and Brown skin. This is because the more melanin present in skin, the greater the risk of inflammation, scarring and hyperpigmentation, which can leave the skin with dark pigmentation spots.​

As this is a zero-damage cosmetic laser technology, there is no risk of scarring to skin which makes it a safe cosmetic solution for all skin tones. This is what sets LYMA Laser technology apart from other cosmetic laser technology and a safe solution for people with Black and Brown skin.​

When it comes to home beauty devices LYMA’s laser technology is unique, offering monochromatic, coherent and polarized laser light, which can trigger regeneration to transform wrinkles, scars and blemishes. Conversely the light from LED devices is omnidirectional, this means that it lacks the penetrative ability of monochromatic laser light, experts estimate up to 95% of LED light bounces off the surface of the skin, and doesn’t have the power to trigger cell renewal.

The technology utilised in the LYMA Laser is used in hospitals across the world for its ability to regenerate skin, tissue and muscle, safely and painlessly. LYMA has engineered this proven science to develop devices that bring clinic power and unrivalled results for home use.  

LYMA’s powerful zero-damage lasers offer clinic-grade results with no pain or downtime. While other at home lasers and beauty devices trigger the stress damage response, harming the skin in order to activate regeneration, LYMA’s technology offers superior renewal by delivering monochromatic, coherent and polarized near-infrared low-level laser light at the precise wavelength, 808nm, which will improve the skin, with no damage. It is this superior science that allows those with melanin rich skin tones to use the LYMA Laser for skin rejuvenation with no danger of scarring whatsoever. 

The LYMA Laser and Laser PRO are safe to use on areas that have received injectables or other cosmetic treatments.​Unlike devices that rely on a stress-damage response, the LYMA Laser and Laser PRO does not compromise the integrity of these treatments, nor does it cause sensitivity or further damage to the skin.

In fact, the Laser is highly anti-inflammatory and can help to reduce bruising and swelling following treatment. It also promotes wound healing, making it an excellent choice for use after more invasive procedures. ​

It is safe to use the LYMA Laser and Laser PRO during pregnancy; however, we advise against using it on or around the abdominal area. The LYMA Laser is also entirely safe to use on any area of the body following pregnancy.​ Always consult your doctor if you have concerns regarding an on-going medical issue.

Yes, you can use the LYMA Laser and Laser PRO if you are using a topical Retinal/Retinol/Vitamin A. ​

Your LYMA Laser PRO Starter Kit includes Oxygen Mist and Oxygen Glide, which have been optimized for use with the LYMA Laser PRO to give exceptional results. ​​However, we know everyone has their favorite products, and you can incorporate the LYMA Laser PRO with most skincare, LYMA Concierge can offer advice and recommendations. ​

​

No, they are not red light devices. The LYMA Laser and LYMA Laser PRO are engineered to deliver powerful, near-infrared, cold laser light at 808nm. Because near-infrared laser light is invisible to the human eye, LYMA Lasers are engineered with red LED lights at 620nm to indicate when the devices are switched on.

The LYMA Laser was used in a pre-clinical and clinical study on the gene expression profile of human skin, evaluating its wound healing potential.

For this phase 1 clinical trial, a total of 20 patients with non-healing wounds were recruited. The study compared the low-level laser light of the LYMA Laser with LED and a negative control (standard wound dressing) over a five day period, on day 6 skin samples were biopsied for RNA extraction and gene expression assays run for 107 genes of interest.

The study showed the LYMA Laser altered expression of 45 genes. Highly upregulated genes (>5-fold change) included those implicated in wound healing and anti-ageing. The LYMA Laser reduced mean wound area by 78% and healed 4 of 10 wounds completely. By contrast, 8 of 10 of those receiving standard care with no LYMA Laser exhibited no change.

This study authored by Dr Graeme Glass PhD, FRCS (Plast) was published in Aesthetic Surgery Journal for peer-review.

LYMA commissioned a 90 day study with 60 subjects clinically evaluated after using the LYMA Laser. The study showed a statistically significant improvement when looking at overall skin satisfaction, as well as forehead wrinkles, lip wrinkles, marionette lines, nasolabial folds and overall face wrinkles.

The subjects included a variety of ages and skin tones (55% fair skin, 38% melanin rich skin) and a mix of skin types, using the Fitzpatrick scale.

Read the study here

The LYMA Laser was involved in a clinical trial utilising an APM-100 analyser on 10 subjects under professional observation, the following results were reported:

• 64.3% improvement in appearance of pigmentation
• 53.8% improvement in depth and appearance of wrinkles
• 42% improvement in symptoms of rosacea
• 56% decline in appearance of acne and blemishes

Results were observed over a 5 week treatment period with each subject using the LYMA Laser twice daily with LYMA Mist & Glide. The APM 100 is a professional skin analysis device. It measures the level of moisture and analyses the skin conditions of sebum, pore, melanin, acne, wrinkle and sensitivity.

Customer safety is our primary concern. Clinical and preclinical evidence suggests that photobiomodulation is oncologically safe for skin rejuvenation, and there is no evidence to support that it should be avoided by patients who have previously undergone treatment for cancer.

A thorough review of the evidence was published in Aesthetic Surgery Journal (Volume 43, Issue 5, May 2023) Photobiomodulation: A Systematic Review of the Oncologic Safety of Low-Level Light Therapy for Aesthetic Skin Rejuvenation by Dr Graeme Glass PhD, FRCS (Plast).

Read the study here.

LYMA conducted a trial of 50 people with an average age of 49 to determine changes in the appearance and texture of skin after the application of LYMA Skincare (Serum and Cream) and using the LYMA Laser for a 3 month period. The study showing skin hydration was improved by an average of 72%, skin elasticity was improved by an average of 24% and skin redness was reduced by an average of 21%.

The machines used in the trial are validated for the purpose of consumer testing:
1. Skin elasticity was measured using Cutometer Dual MPA 580 device
2. Skin hydration was measured using the Corneometer CM 825 device
3. Skin redness was measured Using Colorimeter CL-400 device

You can read the full study here.

Dr Graeme Glass PhD, FRCS (Plast) authored a paper titled Cosmeceuticals: The Principles and Practice of Skin Rejuvenation by Nonprescription Topical Therapy, published in Aesthetic Surgery Journal.

The paper looks to classify cosmeceuticals by method of action, explain how they work in principle with reference to skin aging, and evaluate the clinical evidence for them. The paper explores the role of beta glucans, a key ingredient in LYMA’s Glide, in skin regeneration.

The paper concludes beta-glucans have been shown to enhance migration and proliferation of human dermal fibroblasts in vitro. Preclinical studies have provided evidence of enhanced wound healing by increasing the wound tensile strength, which was attributed to the enhanced collagen biosynthesis.

Read the full study here.

As low-level laser therapy becomes more widely used in medical practices, and now with the LYMA Laser, at home, Dr Graeme Glass PhD, FRCS (Plast) authored a journal exploring and summarising the clinical evidence for its use as a safe and effective method of skin rejuvenation, acne vulgaris, wound healing, body contouring, and androgenic alopecia.

Dr Glass concludes there is a reasonable body of clinical trial evidence to support the role of low-energy red/near-infrared light as a safe and effective method of skin rejuvenation, treatment of acne vulgaris and alopecia, and, especially, body contouring.

Read the full study here.

The LYMA Laser utilises Photobiomodulation to trigger skin rejuvenation and renewal. Scientific research proves the effect of photobiomodulation and light therapy’s healing properties on the cells, as in this independent peer-reviewed in vitro study: Topaloglu, Nermin, Merve Özdemir, and Ziyşan Buse Yaralı Çevik. Photodermatology, Photoimmunology & Photomedicine 37.3 (2021): 253-262.

Read the full study here.

The lack of regulatory standards in the low-level light therapy space makes it difficult to draw clear conclusions about efficacy and safety, therefore LYMA’s Aesthetic Director Dr Graeme Glass PhD, FRCS (Plast) authored a review of the molecular evidence available for light therapy used therapeutically.

The paper explores the development of Photobiomodulation as a clinical concept, and examines the evidence to summarize the science behind Photobiomodulation.

Read the full study here.